LYFT vs REGN · P/E 108, rev $5.79B vs P/E 14, rev $14.34B
LYFT Inc (LYFT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LYFT and REGN stock pages for the full models.
Not investment advice.